A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 38/18 (2006.01) A61K 47/48 (2006.01)
Patent
CA 2442159
The invention relates to treatments of neuropathic pain, including tactile allodynia, and to treatments for reducing loss of pain sensitivity associated with neurophathy. The present treatments involve the use of neublastin (NBN) polypeptides.
L'invention concerne des traitements de la douleur neuropathique, y compris l'allodynie tactile, et des traitements de réduction de la perte de sensibilité à la douleur associée à la neurophathie. Lesdits traitements comprennent l'utilisation de polypeptides de neublastine (NBN).
Biogen Inc.
Biogen Idec Ma Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Treatment using neublastin polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment using neublastin polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment using neublastin polypeptides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1497726